lifestyle.capitolhilltimes.com

Author: MaxCyte, Inc

MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

March 31, 2026
MaxCyte Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance

March 24, 2026
MaxCyte Appoints Parmeet Ahuja as Chief Financial Officer

March 23, 2026
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery

February 24, 2026
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

February 23, 2026